Abstract
We present the case of a 2-month-old infant with reticular dysgenesis who was treated with recombinant granulocyte-macrophage colony stimulating factor with the aim of stimulating granulopoiesis while awaiting bone marrow transplant.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have